Lisdexamfetamine Dimesylate Capsules Solicitation
DLA
PHILADELPHIA, PA
DLA
PHILADELPHIA, PA
A strong match for healthcare vendors
Curated for medical & healthcare suppliers
Title explicitly names Lisdexamfetamine Dimesylate Capsules, a prescription stimulant medication; DLA pharmaceutical solicitations fall directly under the pharmaceuticals scoring anchor (90-100).
Deadline: Jul 2, 2026 at 12:00 AM
Is the original source link not working? Let us know so we can fix it.
Broken link reported
We may use AI to analyze and summarize bid information. Please verify details at the original source.
Ref No.
MX-147801
Unlock full access to browse all bids